Raymond James & Associates’s Medifast MED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,021
| Closed | -$209K | – | 3845 |
|
|
2023
Q1 | $209K | Buy |
+2,021
| New | +$209K | ﹤0.01% | 3438 |
|
|
2022
Q4 | – | Sell |
-8,895
| Closed | -$964K | – | 3848 |
|
|
2022
Q3 | $964K | Sell |
8,895
-10,222
| -53% | -$1.11M | ﹤0.01% | 2409 |
|
|
2022
Q2 | $3.45M | Buy |
19,117
+4,567
| +31% | +$824K | ﹤0.01% | 1652 |
|
|
2022
Q1 | $2.49M | Buy |
14,550
+11,843
| +437% | +$2.02M | ﹤0.01% | 1975 |
|
|
2021
Q4 | $567K | Sell |
2,707
-944
| -26% | -$198K | ﹤0.01% | 2981 |
|
|
2021
Q3 | $703K | Buy |
3,651
+2,779
| +319% | +$535K | ﹤0.01% | 2808 |
|
|
2021
Q2 | $247K | Sell |
872
-1,864
| -68% | -$528K | ﹤0.01% | 3535 |
|
|
2021
Q1 | $580K | Buy |
2,736
+373
| +16% | +$79.1K | ﹤0.01% | 2897 |
|
|
2020
Q4 | $464K | Sell |
2,363
-4,054
| -63% | -$796K | ﹤0.01% | 2849 |
|
|
2020
Q3 | $1.06M | Sell |
6,417
-916
| -12% | -$151K | ﹤0.01% | 2141 |
|
|
2020
Q2 | $1.02M | Buy |
7,333
+324
| +5% | +$44.9K | ﹤0.01% | 2144 |
|
|
2020
Q1 | $438K | Sell |
7,009
-470
| -6% | -$29.4K | ﹤0.01% | 2495 |
|
|
2019
Q4 | $820K | Buy |
7,479
+2,345
| +46% | +$257K | ﹤0.01% | 2390 |
|
|
2019
Q3 | $532K | Buy |
+5,134
| New | +$532K | ﹤0.01% | 2603 |
|
|
2018
Q4 | – | Sell |
-2,739
| Closed | -$607K | – | 3509 |
|
|
2018
Q3 | $607K | Buy |
2,739
+170
| +7% | +$37.7K | ﹤0.01% | 2568 |
|
|
2018
Q2 | $411K | Buy |
2,569
+300
| +13% | +$48K | ﹤0.01% | 2809 |
|
|
2018
Q1 | $212K | Buy |
+2,269
| New | +$212K | ﹤0.01% | 3086 |
|